English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Conference Paper

Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor.

MPS-Authors
/persons/resource/persons45923

Ryazanov,  S.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15438

Leonov,  A.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons16093

Zweckstetter,  M.
Research Group of Protein Structure Determination using NMR, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15947

Urlaub,  H.
Research Group of Bioanalytical Mass Spectrometry, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger,  C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Levin, J., Wagner, J., Ryazanov, S., Leonov, A., Shi, S., Schmidt, F., et al. (2011). Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. Movement Disorders, 26(Supplement 2), S21-S21.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000F-4202-0
Abstract
There is no abstract available